<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03427736</url>
  </required_header>
  <id_info>
    <org_study_id>Pro00088893</org_study_id>
    <nct_id>NCT03427736</nct_id>
  </id_info>
  <brief_title>Anesthetics and Analgesics in Children</brief_title>
  <acronym>ANA01</acronym>
  <official_title>Pharmacokinetics of Anesthetics and Analgesics in Children and Adolescent</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kanecia Zimmerman, MD MPH</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>The Emmes Company, LLC</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Duke University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to characterize the pharmacokinetic (PK) and safety profile of
      anesthetics and analgesics in children and adolescents.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a research study to find out what the side effects are of certain drugs that are
      commonly used for pain and to put people to sleep for surgery. The researchers also want to
      know how the drug is broken down in the body. Participants will be given these drugs as they
      are prescribed by their regular doctor. As part of the participant's standard of care,
      doctors will perform tests, ask questions, review medical information and measure vital signs
      (heart rate, blood pressure, etc). The researchers will collect information that doctors have
      already written in the medical records. The research study team will collect blood from
      participants at certain time points depending on when the participant was first given the
      drug (up to 5 samples over the course of 10 to 48 hours). Parents will complete
      questionnaires about the study participant. Parents will continue to complete those same
      questionnaires for up to 12 months after the participant was first given the drug. Examples
      of current and upcoming anesthetics and analgesics include, but are not limited to:
      hydromorphone (Dilaudid), ketorolac (Toradol), methadone and ketamine.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 13, 2018</start_date>
  <completion_date type="Anticipated">September 2021</completion_date>
  <primary_completion_date type="Anticipated">September 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Clearance (CL) or apparent oral clearance (CL/F)</measure>
    <time_frame>up to 48 hours post dose</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Volume of distribution (V) or apparent oral volume of distribution (V/F)</measure>
    <time_frame>up to 48 hours post dose</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Elimination rate constant (ke)</measure>
    <time_frame>up to 48 hrs post dose</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Half-life (t1/2)</measure>
    <time_frame>up to 48 hrs post dose</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Absorption rate constant (ka)</measure>
    <time_frame>up to 48 hrs post dose</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Area under the curve (AUC)</measure>
    <time_frame>up to 48 hrs post dose</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Maximum concentration (CMAX)</measure>
    <time_frame>up to 48 hrs post dose</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Time to achieve maximum concentration (TMAX)</measure>
    <time_frame>up to 48 hrs post dose</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Anesthesia</condition>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>Drug of Interest</arm_group_label>
    <description>Individuals receiving anesthetics or analgesics per standard of care</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ketorolac Tromethamine</intervention_name>
    <description>IV ketorolac will be given per standard of care, not prescribed for this study</description>
    <arm_group_label>Drug of Interest</arm_group_label>
    <other_name>Toradol</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Hydromorphone</intervention_name>
    <description>IV Hydromorphone will be given per standard of care, not prescribed for this study</description>
    <arm_group_label>Drug of Interest</arm_group_label>
    <other_name>Hydromorphone hydrochloride</other_name>
    <other_name>Dilaudid</other_name>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Left over specimens may be sent to the NICHD biorepository at the consent of the study
      participant. This is optional. But future unspecified tests conducted may include genetic
      testing.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Approximately 60 participants will be enrolled to each of the study drug of interests (DOI)
        cohorts. Participants who satisfy eligibility criteria and are receiving one or more DOIs
        per standard of care will be consented into the study and assigned to the corresponding DOI
        cohort. DOI cohort assignments will be at the discretion of the treating physician based on
        the DOIs that are administered per standard of care. Participants will be selected from a
        variety of centers including but not limited to trauma and intensive care units.
        Participants will not be randomized. Participants may count towards 1 or more DOIs within
        the same 90-day period.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  2 years to &lt; 18 years at the time of enrollment

          -  Parent is able to understand the consent process and provides informed consent/HIPAA

          -  Participant provides assent and as required by the institutional review board

          -  Receiving one or more drugs of interest (DOI) per local standard of care meeting
             DOI-specific inclusion criteria

        Exclusion Criteria:

          -  Known pregnancy

          -  Extracorporeal life support (i.e., Extracorporeal membrane oxygenation, dialysis,
             ventricular assist device)

          -  Any condition which would make the participant, in the opinion of the investigator,
             unsuitable for the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>2 Years</minimum_age>
    <maximum_age>17 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kanecia Zimmerman</last_name>
    <role>Principal Investigator</role>
    <affiliation>Duke Clinical Research Institute</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Cheryl Alderman</last_name>
    <phone>919-668-8349</phone>
    <email>cheryl.alderman@duke.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Phyllis Kennel</last_name>
    <phone>919-668-9958</phone>
    <email>phyllis.kennel@duke.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of California San Francisco</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94143</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Scott Schulman, MD</last_name>
      <phone>415-502-4222</phone>
      <email>scott.schulman@ucsf.edu</email>
    </contact>
    <contact_backup>
      <last_name>Anne Mckenzie</last_name>
      <phone>1-415-476-3758</phone>
      <email>anne.mckenzie@ucsf.edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Lucile Packard Children's Hospital</name>
      <address>
        <city>Stanford</city>
        <state>California</state>
        <zip>94305</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexandria George</last_name>
      <phone>650-232-9152</phone>
      <email>josepha3@stanford.edu</email>
    </contact>
    <contact_backup>
      <last_name>Yan He</last_name>
      <phone>1-650-724-2320</phone>
      <email>yh52@stanford.edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Children's Hospital Colorado</name>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <zip>80045</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Peter Mourani, MD</last_name>
      <phone>303-724-2390</phone>
      <email>peter.mourani@childrenscolorado.org</email>
    </contact>
    <contact_backup>
      <last_name>Alle Rutebemberwa</last_name>
      <phone>1-720-777-5380</phone>
      <email>alle.rutebemberwa@childrenscolorado.org</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Alfred I. DuPont Hospital for Children</name>
      <address>
        <city>Wilmington</city>
        <state>Delaware</state>
        <zip>19803</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marisa Meyer, MD</last_name>
      <phone>302-651-4021</phone>
      <email>marisa.meyer@nemours.org</email>
    </contact>
    <contact_backup>
      <last_name>Ramany John</last_name>
      <phone>1-302-298-7521</phone>
      <email>ramany.john@nemours.org</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Cardinal Glennon Children's Hospital</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marian Malone</last_name>
      <phone>314-577-5395</phone>
      <email>marian.malone@health.slu.edu</email>
    </contact>
    <contact_backup>
      <last_name>Erik Madsen, MD</last_name>
      <phone>314-577-1590</phone>
      <email>madsenec@slu.edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Washington University School of Medicine</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mike Montana, MD, PhD</last_name>
      <phone>314-565-8119</phone>
      <email>montana@wustl.edu</email>
    </contact>
    <contact_backup>
      <last_name>Dani Tallchief, RN</last_name>
      <phone>314-747-1663</phone>
      <email>dtallchief@wustl.edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>University of New Mexico, Health Sciences Center</name>
      <address>
        <city>Albuquerque</city>
        <state>New Mexico</state>
        <zip>87131</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Olivia Nunez</last_name>
      <phone>505-272-9898</phone>
      <email>odnunez@salud.unm.edu</email>
    </contact>
    <contact_backup>
      <last_name>Sarah Sanders</last_name>
      <phone>1-505-272-8111</phone>
      <email>sreinh@salud.unm.edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Duke University Medical Center</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27701</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Melissa Harward</last_name>
      <phone>919-668-3910</phone>
      <email>Melissa.Harward@duke.edu</email>
    </contact>
    <contact_backup>
      <last_name>Chi Hornik</last_name>
      <phone>919.970.6680</phone>
      <email>chi.dang@duke.edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Oregon Health and Science University</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97239</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kimberly Grzesek</last_name>
      <phone>503-494-2797</phone>
      <email>grzesek@ohsu.edu</email>
    </contact>
    <contact_backup>
      <last_name>Sarah Craven</last_name>
      <phone>1-503-418-6676</phone>
      <email>cravens@ohsu.edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Medical University of South Carolina</name>
      <address>
        <city>Charleston</city>
        <state>South Carolina</state>
        <zip>29425</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>John Costello, MD</last_name>
      <phone>843-792-9570</phone>
      <email>costello@musc.edu</email>
    </contact>
    <contact_backup>
      <last_name>Andrew Atz, MD</last_name>
      <phone>843-876-1698</phone>
      <email>atzam@musc.edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Vanderbilt University</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37232</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jennifer King, MD</last_name>
      <phone>615-963-1302</phone>
      <email>jennifer.c.king@vumc.org</email>
    </contact>
    <contact_backup>
      <last_name>Diana Coman</last_name>
      <phone>1-615-875-9700</phone>
      <email>diana.l.coman@vumc.org</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Baylor College of Medicine</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dean Andropoulos</last_name>
      <phone>832-826-5832</phone>
      <email>dbandrop@texaschildrens.org</email>
    </contact>
    <contact_backup>
      <last_name>Margaret Owens-Stuberfield</last_name>
      <phone>832-824-5913</phone>
      <email>mxowenss@texaschildrens.org</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>University of Texas Health Science Center</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jon Meliones</last_name>
      <phone>713-500-5359</phone>
      <email>Jon.Meliones@uth.tmc.edu</email>
    </contact>
    <contact_backup>
      <last_name>Alvaro Coronado Munoz</last_name>
      <phone>713-500-5553</phone>
      <email>Alvaro.J.CoronadoMunoz@uth.tmc.edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>The Hospital for Sick Children</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5G 1X8</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Yaron Finkelstein</last_name>
      <phone>416-813-5317</phone>
      <email>yaron.finkelstein@sickkids.ca</email>
    </contact>
    <contact_backup>
      <last_name>Maggie Rumantir</last_name>
      <phone>416-813-7654</phone>
      <email>maggie.rumantir@sickkids.ca</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Hospital Sainte-Justine</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <zip>T3T 1C5</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Julie Autmizguine</last_name>
      <phone>514-345-4931</phone>
      <email>julie.autmizguine@umontreal.ca</email>
    </contact>
    <contact_backup>
      <last_name>Mariana Dumitrascu</last_name>
      <phone>514-345-4931</phone>
      <email>mariana.dumitrascu@recherche-ste-justine.qc.ca</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Canada</country>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>February 2, 2018</study_first_submitted>
  <study_first_submitted_qc>February 8, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">February 9, 2018</study_first_posted>
  <last_update_submitted>May 4, 2020</last_update_submitted>
  <last_update_submitted_qc>May 4, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 5, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Duke University</investigator_affiliation>
    <investigator_full_name>Kanecia Zimmerman, MD MPH</investigator_full_name>
    <investigator_title>Assistant Professor of Pediatrics</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ketorolac</mesh_term>
    <mesh_term>Ketorolac Tromethamine</mesh_term>
    <mesh_term>Hydromorphone</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>All data collected is uploaded into the National Institute of Health data repository (DASH) at the end of the study (de-identified).</ipd_description>
    <ipd_time_frame>Data will be uploaded to the repository within 2 years of study completion. It will be maintained in the repository indefinitely.</ipd_time_frame>
    <ipd_access_criteria>In order to have access, researchers have to complete a Data access request. NICHD will review the request and either approve or deny it. IRB approval must be obtained by the researcher to access the data.
https://dash.nichd.nih.gov/Resource/DataRequestChecklist</ipd_access_criteria>
    <ipd_url>https://dash.nichd.nih.gov/</ipd_url>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

